Literature DB >> 11526216

A role for IL-1 alpha in inducing pathologic inflammation during bacterial infection.

P H Dube1, P A Revell, D D Chaplin, R G Lorenz, V L Miller.   

Abstract

Infection with pathogenic microbes often results in a significant inflammatory response. A cascade of proinflammatory cytokines including tumor necrosis factor alpha (TNF-alpha) and IL-1 initiates this response. Although there is a clear role for IL-1 during infection, little is known to distinguish the role of IL-1 alpha from that of IL-1 beta during this process. With the use of Yersinia enterocolitica as a model enteric pathogen, we have identified a specific role for IL-1 alpha in inducing pathologic inflammation during bacterial infection. Depletion of IL-1 alpha in mice infected with wild-type Y. enterocolitica results in significantly decreased intestinal inflammation. Furthermore, a bacterial mutant that does not induce IL-1 alpha expression but induces normal levels of IL-1 beta, TNF-alpha, and IFN-gamma, causes greatly reduced intestinal inflammation and is attenuated by LD(50) analysis in the C57BL/6 mouse model. These results demonstrate a distinct and unrecognized role for IL-1 alpha in inducing intestinal inflammation that cannot be compensated for by the endogenous levels of IL-1 beta, TNF-alpha, or IFN-gamma that are produced in response to Y. enterocolitica. Additionally, these results suggest that IL-1 alpha-induced inflammation is a major contributor to the pathology of yersiniosis.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11526216      PMCID: PMC58568          DOI: 10.1073/pnas.191214498

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  21 in total

1.  Inhibition of the mitogen-activated protein kinase kinase superfamily by a Yersinia effector.

Authors:  K Orth; L E Palmer; Z Q Bao; S Stewart; A E Rudolph; J B Bliska; J E Dixon
Journal:  Science       Date:  1999-09-17       Impact factor: 47.728

2.  YopJ of Yersinia spp. is sufficient to cause downregulation of multiple mitogen-activated protein kinases in eukaryotic cells.

Authors:  L E Palmer; A R Pancetti; S Greenberg; J B Bliska
Journal:  Infect Immun       Date:  1999-02       Impact factor: 3.441

Review 3.  Interleukin-1: basic science and clinical applications.

Authors:  R Patarca; M A Fletcher
Journal:  Crit Rev Oncog       Date:  1997

Review 4.  The Yersinia Yop virulon: a bacterial system for subverting eukaryotic cells.

Authors:  G R Cornelis; H Wolf-Watz
Journal:  Mol Microbiol       Date:  1997-03       Impact factor: 3.501

5.  Identification of Yersinia enterocolitica genes affecting survival in an animal host using signature-tagged transposon mutagenesis.

Authors:  A J Darwin; V L Miller
Journal:  Mol Microbiol       Date:  1999-04       Impact factor: 3.501

6.  Identification of novel chromosomal loci affecting Yersinia enterocolitica pathogenesis.

Authors:  G M Young; V L Miller
Journal:  Mol Microbiol       Date:  1997-07       Impact factor: 3.501

Review 7.  Interleukin-1.

Authors:  C A Dinarello
Journal:  Cytokine Growth Factor Rev       Date:  1997-12       Impact factor: 7.638

8.  Role of interleukin-1 in the pathogenesis of experimental shigellosis.

Authors:  P J Sansonetti; J Arondel; J M Cavaillon; M Huerre
Journal:  J Clin Invest       Date:  1995-08       Impact factor: 14.808

9.  Mice deficient in IL-1beta manifest impaired contact hypersensitivity to trinitrochlorobenzone.

Authors:  L P Shornick; P De Togni; S Mariathasan; J Goellner; J Strauss-Schoenberger; R W Karr; T A Ferguson; D D Chaplin
Journal:  J Exp Med       Date:  1996-04-01       Impact factor: 14.307

10.  Acute inflammation causes epithelial invasion and mucosal destruction in experimental shigellosis.

Authors:  O J Perdomo; J M Cavaillon; M Huerre; H Ohayon; P Gounon; P J Sansonetti
Journal:  J Exp Med       Date:  1994-10-01       Impact factor: 14.307

View more
  32 in total

1.  Identification of a locus involved in systemic dissemination of Yersinia enterocolitica.

Authors:  K M Nelson; G M Young; V L Miller
Journal:  Infect Immun       Date:  2001-10       Impact factor: 3.441

Review 2.  Interleukin 1α and the inflammatory process.

Authors:  Nelson C Di Paolo; Dmitry M Shayakhmetov
Journal:  Nat Immunol       Date:  2016-07-19       Impact factor: 25.606

3.  Mycoplasma pneumoniae CARDS toxin induces pulmonary eosinophilic and lymphocytic inflammation.

Authors:  Jorge L Medina; Jacqueline J Coalson; Edward G Brooks; Vicki T Winter; Adriana Chaparro; Molly F R Principe; Thirumalai R Kannan; Joel B Baseman; Peter H Dube
Journal:  Am J Respir Cell Mol Biol       Date:  2012-01-26       Impact factor: 6.914

4.  Interleukin-1 receptor signaling is required to overcome the effects of pertussis toxin and for efficient infection- or vaccination-induced immunity against Bordetella pertussis.

Authors:  Xuqing Zhang; Sara E Hester; Mary J Kennett; Alexia T Karanikas; Liron Bendor; David E Place; Eric T Harvill
Journal:  Infect Immun       Date:  2010-10-25       Impact factor: 3.441

Review 5.  Secretion without Golgi.

Authors:  Igor Prudovsky; Francesca Tarantini; Matteo Landriscina; David Neivandt; Raffaella Soldi; Aleksandr Kirov; Deena Small; Karuppanan Muthusamy Kathir; Dakshinamurthy Rajalingam; Thallapuranam Krishnaswamy Suresh Kumar
Journal:  J Cell Biochem       Date:  2008-04-01       Impact factor: 4.429

6.  Tissue dual RNA-seq allows fast discovery of infection-specific functions and riboregulators shaping host-pathogen transcriptomes.

Authors:  Aaron M Nuss; Michael Beckstette; Maria Pimenova; Carina Schmühl; Wiebke Opitz; Fabio Pisano; Ann Kathrin Heroven; Petra Dersch
Journal:  Proc Natl Acad Sci U S A       Date:  2017-01-17       Impact factor: 11.205

7.  Inhibition of secretion of interleukin-1alpha and tumor necrosis factor alpha by the ketolide antibiotic telithromycin.

Authors:  Fausto G Araujo; Teri L Slifer; Jack S Remington
Journal:  Antimicrob Agents Chemother       Date:  2002-10       Impact factor: 5.191

8.  Contribution of glutathione peroxidase to the virulence of Streptococcus pyogenes.

Authors:  Audrey Brenot; Katherine Y King; Blythe Janowiak; Owen Griffith; Michael G Caparon
Journal:  Infect Immun       Date:  2004-01       Impact factor: 3.441

9.  A Crohn's disease variant in Atg16l1 enhances its degradation by caspase 3.

Authors:  Aditya Murthy; Yun Li; Ivan Peng; Mike Reichelt; Anand Kumar Katakam; Rajkumar Noubade; Merone Roose-Girma; Jason DeVoss; Lauri Diehl; Robert R Graham; Menno van Lookeren Campagne
Journal:  Nature       Date:  2014-02-19       Impact factor: 49.962

10.  YopH inhibits early pro-inflammatory cytokine responses during plague pneumonia.

Authors:  Angelene M Cantwell; Sarah S Bubeck; Peter H Dube
Journal:  BMC Immunol       Date:  2010-06-16       Impact factor: 3.615

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.